Type 2 diabetic peripheral neuropathy
Conditions
Interventions
Control group:No
Experimental group:Lycium ruthenicum Murr.was consumed 5g per person per day
Sponsors
Ningxia Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years; 2. Consistent with type 2 diabetes; 3. Consistent with diabetic peripheral neuropathy; 4. Duration of diabetes for at least 4 years; 5. Good blood sugar control, HbA1c 6.5%-7.5%; 6. The patient has agreed to participate in this study and has signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Neuropathy caused by other causes; 2. Pregnant women and lactating patients; 3. Patients with gastrointestinal diseases and small intestine surgery involved; 4. Patients with liver and kidney failure; 5. Patients who received Chinese herbal medicine, dietary supplements, neurological drugs (epalrestat, mecobalamin) and other treatments one month ago; 6. Patients with wolfberry allergy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nerve conduction velocity;nerve growth factor; | — |
Secondary
| Measure | Time frame |
|---|---|
| Malondiadehyde;C-reaction protein; | — |
Countries
China
Contacts
Public ContactGao Qinghan
Ningxia Medical University
Outcome results
None listed